MedTrace Logo

Pharmacokinetic Comparison of Vitamin's D2 and D3 in Stage 5 Chronic Kidney Disease Patients on Chronic Hemodialysis

NCT01675557 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-02-26

No results posted yet for this study

Summary

The purpose of this study is to compare the pharmacokinetic 25(OH)D and 1,25(OH)2D responses to a single oral dose of vitamin D2 or vitamin D3 in a group of Stage 5-Chronic Kidney Disease subjects requiring chronic hemodialysis.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

a single oral dose of vitamin D3

DIETARY_SUPPLEMENT

Vitamin D2

a single oral dose of vitamin D2

DIETARY_SUPPLEMENT

Placebo

a single oral dose of placebo

Sponsors & Collaborators

  • Creighton University

    lead OTHER

Principal Investigators

  • Laura AG Armas, MD,MS · Creighton University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01675557 on ClinicalTrials.gov